Table 1 Expression profile of the studied markers in DLBCL patients.
Expression results | Number | Percent (%) | Median fold regulation |
|---|---|---|---|
miR-222-3p | |||
Up | 29 | 72.5 | 3 (min. 3–max.141) |
Down | 11 | 27.5 | − 27.02 (min. − 500 to max. − 2.07) |
miR-26b-5p | |||
Up | 29 | 72.5 | 2.5 (min. 2.5–max. 110.35) |
Down | 11 | 27.5 | − 33.33 (min. − 500 to max − 2.439) |
ebv-miR-BHRF1-2-5p | |||
Up | 25 | 62.5 | 50.861 (min. 2.585–max. 2340.33) |
Down | 6 | 15 | − 164.04 (min. − 1533.84 to max.− 7.69) |
Normal | 9 | 22.5 | 1.109 (min. − 1.17 to max 1.745) |
ebv-miR-BHRF1-2-3p | |||
Up | 27 | 67.5 | 3.458 (min. 3.458—max. 13.689) |
Down | 13 | 32.5 | − 28.49 (min. − 90.09 to max. − 8.19) |
BMI-1 | |||
+ Ve | 27 | 67.5 | – |
− Ve | 13 | 32.5 | – |
PIM-2 | |||
+ Ve | 31 | 77.5 | – |
− Ve | 9 | 22.5 | – |
